Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）

NCT05429463 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: Sintilimab
DRUG: Carboplatin
DRUG: Albumin-Bound Paclitaxel

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University